Market Overview

SenesTech Announces Pricing of $4.1 Million Public Offering of Common Stock

Share:

FLAGSTAFF, Ariz., July 11, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced  the pricing of its previously announced public offering of 3,037,038 shares of its common stock at a price to the public of $1.35 per share. SenesTech expects to receive aggregate gross proceeds of approximately $4.1 million from the offering. The offering is expected to close on or about July 16, 2019, subject to customary closing conditions.

SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product, ContraPest(R), is marketed for use initially in controlling rat infestations. (PRNewsfoto/SenesTech, Inc.) (PRNewsfoto/SenesTech, Inc.)

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

SenesTech intends to use the net proceeds from the offering for working capital and other general corporate purposes.

The shares of common stock are being offered by SenesTech pursuant to a "shelf" registration statement on Form S-3 (Registration No. 333-225712) previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on August 24, 2018. A preliminary prospectus supplement describing the terms of the offering was filed with the SEC on July 11, 2019, and is available on the SEC's website at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained, when available, from H.C. Wainwright & Co., LLC, 430 Park Avenue 3rd Floor, New York, NY 10022, or by calling (646) 975-6996 or by emailing placements@hcwco.com or at the SEC's website at http://www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. Any offer, if at all, will be made only by means of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.

About SenesTech
SenesTech has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. For more information visit the SenesTech website at www.senestech.com.

Safe Harbor Statement
This release contains "forward-looking statements" that involve estimates, assumptions, risks and uncertainties. Any forward-looking statements describe future expectations, beliefs, plans, results, objectives, assumptions or strategies  and are generally preceded by words such as "may," "future," "plan" or "planned," "will," "should," "expected," "anticipates," "draft," "continue," "eventually," "believes," or "projected." Forward-looking statements include, but are not limited to, statements regarding the Company's expectations on the completion and timing of the public offering and the anticipated use of proceeds therefrom; deployment of the Company's product; the continuation or expansion of the use of ContraPest; demand for ContraPest; the Company's confidence in its marketing and strategy resulting in growth; the Company's continuing to control cost and improve gross margins and financial results; the Company's expectations on regulatory developments; and the Company's execution of its strategic business plan.

Investors should not unduly rely on forward-looking statements. Such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those made in the forward-looking statements, including risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the public offering as well as uncertainties as result of various factors and other risks, such as market acceptance and demand for the Company's products, customers completing order commitments, the Company's ability to reduce costs and execute on its plans and continuing to believe it is following the best strategy, the Company having sufficient financing, and other factors identified in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K and quarterly reports filed on Form 10-Q. All forward-looking statements speak only as of the date on which they were made based on management's assumptions as of such date. The Company does not undertake any obligation to update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as required by law.

For further information: Investors: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com, or Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/senestech-announces-pricing-of-4-1-million-public-offering-of-common-stock-300883926.html

SOURCE SenesTech, Inc.

View Comments and Join the Discussion!
 
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com